New Study Finds Cranberry Compounds Block Cancer

New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Research Indicates That Common Turmeric Fights Cancer Cells Study published earlier this week in the journal ‘Cancer’, curcumin, the pigment that gives turmeric its yellow tint, also keeps the deadliest skin cancers from dividing and growing and in fact stimulates apoptosis—or intracellular death which causes cancer cells to kill themselves. Research Indicates That Common Turmeric Fights Cancer Cells Study published earlier this week in the journal ‘Cancer’, curcumin, the pigment that gives turmeric its yellow tint, also keeps the deadliest skin cancers from dividing and growing and in fact stimulates apoptosis—or intracellular death which causes cancer cells to kill themselves. Research Indicates That Common Turmeric Fights Cancer Cells Study published earlier this week in the journal ‘Cancer’, curcumin, the pigment that gives turmeric its yellow tint, also keeps the deadliest skin cancers from dividing and growing and in fact stimulates apoptosis—or intracellular death which causes cancer cells to kill themselves. Common Turmeric Fights Cancer Cells According to a study published this week in the journal 'Cancer', curcumin, the pigment that gives turmeric its yellow tint, also keeps the deadliest skin cancers from dividing and growing and in fact stimulates apoptosis—or intracellular death which causes cancer cells to kill themselves. Curcumin is currently being tested on patients with multiple myeloma, an incurable bone marrow cancer, as well as pancreatic cancer. Common Turmeric Fights Cancer Cells According to a study published this week in the journal 'Cancer', curcumin, the pigment that gives turmeric its yellow tint, also keeps the deadliest skin cancers from dividing and growing and in fact stimulates apoptosis—or intracellular death which causes cancer cells to kill themselves. Curcumin is currently being tested on patients with multiple myeloma, an incurable bone marrow cancer, as well as pancreatic cancer. Cruciferous Vegetables May Help Some People Protect Against Lung Cancer Eating vegetables from the cabbage family could help individuals with a certain genetic make-up reduce their risk of lung cancer, suggests a research letter in this week’s issue of The Lancet. The researchers found that weekly consumption of cruciferous vegetables had a 33% protective effect against lung cancer in people who had an inactive form of the GSTM1 gene, one gene that produces enzymes that help eliminate isothiocyanates from the body. Cruciferous Vegetables May Help Some People Protect Against Lung Cancer Eating vegetables from the cabbage family could help individuals with a certain genetic make-up reduce their risk of lung cancer, suggests a research letter in this week’s issue of The Lancet. The researchers found that weekly consumption of cruciferous vegetables had a 33% protective effect against lung cancer in people who had an inactive form of the GSTM1 gene, one gene that produces enzymes that help eliminate isothiocyanates from the body. Cruciferous Vegetables May Help Some People Protect Against Lung Cancer Eating vegetables from the cabbage family could help individuals with a certain genetic make-up reduce their risk of lung cancer, suggests a research letter in this week’s issue of The Lancet. The researchers found that weekly consumption of cruciferous vegetables had a 33% protective effect against lung cancer in people who had an inactive form of the GSTM1 gene, one gene that produces enzymes that help eliminate isothiocyanates from the body. Cruciferous Vegetables May Help Some People Protect Against Lung Cancer Eating vegetables from the cabbage family could help individuals with a certain genetic make-up reduce their risk of lung cancer, suggests a research letter in this week’s issue of The Lancet. The researchers found that weekly consumption of cruciferous vegetables had a 33% protective effect against lung cancer in people who had an inactive form of the GSTM1 gene, one gene that produces enzymes that help eliminate isothiocyanates from the body. Cruciferous Vegetables May Help Some People Protect Against Lung Cancer Eating vegetables from the cabbage family could help individuals with a certain genetic make-up reduce their risk of lung cancer, suggests a research letter in this week’s issue of The Lancet. The researchers found that weekly consumption of cruciferous vegetables had a 33% protective effect against lung cancer in people who had an inactive form of the GSTM1 gene, one gene that produces enzymes that help eliminate isothiocyanates from the body. Cruciferous Vegetables May Help Some People Protect Against Lung Cancer Eating vegetables from the cabbage family could help individuals with a certain genetic make-up reduce their risk of lung cancer, suggests a research letter in this week’s issue of The Lancet. The researchers found that weekly consumption of cruciferous vegetables had a 33% protective effect against lung cancer in people who had an inactive form of the GSTM1 gene, one gene that produces enzymes that help eliminate isothiocyanates from the body. Study Examines Anticancer Effect of Herbal Medicine in Cancer Cells A new study in cancer cell lines has found that the gamma-linolenic acid (GLA)--a polyunsaturated fatty acid found in several plant oils, affects the expression of the Her-2/neu oncogene, in a different way from the monoclonal antibody approved for treatment of breast cancer patients with high levels of Her-2/neu. Study Examines Anticancer Effect of Herbal Medicine in Cancer Cells A new study in cancer cell lines has found that the gamma-linolenic acid (GLA)--a polyunsaturated fatty acid found in several plant oils, affects the expression of the Her-2/neu oncogene, in a different way from the monoclonal antibody approved for treatment of breast cancer patients with high levels of Her-2/neu. Study Examines Anticancer Effect of Herbal Medicine in Cancer Cells A new study in cancer cell lines has found that the gamma-linolenic acid (GLA)--a polyunsaturated fatty acid found in several plant oils, affects the expression of the Her-2/neu oncogene, in a different way from the monoclonal antibody approved for treatment of breast cancer patients with high levels of Her-2/neu. Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Landmark Study Finds Tea Consumption Associated With Reduced Risk of Ovarian Cancer Study published in the latest issue of Archives of Internal Medicine indicates that black tea consumption is inversely associated with the risk of ovarian cancer. Landmark Study Finds Tea Consumption Associated With Reduced Risk of Ovarian Cancer Study published in the latest issue of Archives of Internal Medicine indicates that black tea consumption is inversely associated with the risk of ovarian cancer. Landmark Study Finds Tea Consumption Associated With Reduced Risk of Ovarian Cancer Study published in the latest issue of Archives of Internal Medicine indicates that black tea consumption is inversely associated with the risk of ovarian cancer. High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Phytoestrogen-rich Foods Protect Against Cancer Scientists at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics have studied the correlation between prostate cancer and phytoestrogen in a large population-based case-control study, determining that men who had a high intake of phytoestrogen-rich food, such as beans (which offered the greatest protection), soya products, linseed, sunflower seeds, berries and peanuts, ran a 26 per cent lower risk of developing prostate cancer. Phytoestrogen-rich Foods Protect Against Cancer Scientists at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics have studied the correlation between prostate cancer and phytoestrogen in a large population-based case-control study, determining that men who had a high intake of phytoestrogen-rich food, such as beans (which offered the greatest protection), soya products, linseed, sunflower seeds, berries and peanuts, ran a 26 per cent lower risk of developing prostate cancer. Phytoestrogen-rich Foods Protect Against Cancer Scientists at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics have studied the correlation between prostate cancer and phytoestrogen in a large population-based case-control study, determining that men who had a high intake of phytoestrogen-rich food, such as beans (which offered the greatest protection), soya products, linseed, sunflower seeds, berries and peanuts, ran a 26 per cent lower risk of developing prostate cancer. Phytoestrogen-rich Foods Protect Against Cancer Scientists at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics have studied the correlation between prostate cancer and phytoestrogen in a large population-based case-control study, determining that men who had a high intake of phytoestrogen-rich food, such as beans (which offered the greatest protection), soya products, linseed, sunflower seeds, berries and peanuts, ran a 26 per cent lower risk of developing prostate cancer. Phytoestrogen-rich Foods Protect Against Cancer Scientists at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics have studied the correlation between prostate cancer and phytoestrogen in a large population-based case-control study, determining that men who had a high intake of phytoestrogen-rich food, such as beans (which offered the greatest protection), soya products, linseed, sunflower seeds, berries and peanuts, ran a 26 per cent lower risk of developing prostate cancer. Phytoestrogen-rich Foods Protect Against Cancer Scientists at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics have studied the correlation between prostate cancer and phytoestrogen in a large population-based case-control study, determining that men who had a high intake of phytoestrogen-rich food, such as beans (which offered the greatest protection), soya products, linseed, sunflower seeds, berries and peanuts, ran a 26 per cent lower risk of developing prostate cancer. New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity Research published in Biochemical and Biophysical Research Communication, (2006 (339), 949-955) suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis. New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity Research published in Biochemical and Biophysical Research Communication, (2006 (339), 949-955) suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis. New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity Research published in Biochemical and Biophysical Research Communication, (2006 (339), 949-955) suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis. New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity Research published in Biochemical and Biophysical Research Communication, (2006 (339), 949-955) suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis. New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity Research published in Biochemical and Biophysical Research Communication, (2006 (339), 949-955) suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis. New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity Research published in Biochemical and Biophysical Research Communication, (2006 (339), 949-955) suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis. Antioxidant That Provides Cellular Protection Gaining Support Among Medical Researchers resentations and publications feature references to pub;ications involving inositol hexaphosphate. Antioxidant That Provides Cellular Protection Gaining Support Among Medical Researchers resentations and publications feature references to pub;ications involving inositol hexaphosphate. Antioxidant That Provides Cellular Protection Gaining Support Among Medical Researchers resentations and publications feature references to pub;ications involving inositol hexaphosphate. Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	First Study to Confirm Cranberry Proanthocyanidins Inhibit Growth of Tumor Cells NORTH DARTMOUTH, Mass., Jan 25, 2006 /PRNewswire via COMTEX/ -- New data shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. That's according to a new study published in this month's issue of The Journal of the Science of Food and Agriculture. The study, led by University of Massachusetts Dartmouth researcher Catherine C. Neto, Ph.D., is one of the first studies to find that the cranberry's anti-cancer activity may come from the unique structure of its PACs. Cranberry's PACs contain a unique A-type structure, while most other fruit contains only the more-common B-type PACs. Researchers prepared PAC-rich fractions from whole cranberry extract and worked with scientists at the University of Wisconsin to characterize their structures. They tested the fractions against eight tumor cell lines and screened for the effect on tumor growth. The fractions inhibited the proliferation of the tumor cell lines without inhibiting the growth of normal embryonic mouse cells. "While previous studies have shown that cranberry extracts inhibit the proliferation of cancer cells, this is the first study to confirm that it's the cranberry PACs that are the active components," said Catherine C. Neto, Ph.D., Associate Professor, Department of Chemistry and Biochemistry at the University of Massachusetts Dartmouth. "This study is a significant step toward helping to establish a body of research that shows cranberry PACs may also work to prevent tumor cell growth in vivo." Cranberry's PACs have a unique "anti-adhesion" mechanism known to protect the body from the harmful E. coli bacteria that cause UTIs. Earlier research shows that it's the A-type PACs in cranberry that are responsible for this anti-adhesion activity while the B-type PACs in other foods show minimal to no activity. Neto's study shows that the cranberry's anti-cancer activity is also due to its A-type PACs. "In light of our findings and previously published studies, cranberries may inhibit the spread of cancer in a variety of ways," said Neto. "Further research is needed to determine the mechanisms associated with each of the cranberry's active phytochemicals." In addition to helping prevent UTIs, other data has suggested that the unique A-type PACs found in cranberry may also prevent the adhesion of bacteria in the stomach and the mouth, with implications for the prevention of stomach ulcers and gum disease.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software